Bone cancer mainly affects children and teens. And current treatments can leave survivors with lifelong side effects like kidney and heart damage, infertility and even the development of new cancers.
Thanks to promising new research led by Associate Professor Christine Hawkins, a new class of anti-cancer agents – SMAC mimetics – are being tested on bone cancer cells. Early tests show that it can be effective in causing the cancer cells to die, while being gentler on the patient than current treatments.
Your donation this Christmas can help cancer research, like the one above, reach clinical trials sooner, where real breakthroughs can be made.